
|Videos|December 9, 2016
Lisa Butterfield on the Nurse's Role in Immunotherapy Treatment
Author(s)Lisa Butterfield, PhD
Lisa Butterfield discusses what nurses should know when treating patients receiving immunotherapies.
Advertisement
Lisa Butterfield, PhD, University of Pittsburgh and president of the Society of Immunotherapy for Cancer (SITC), describes what nurses should know when dealing with immunotherapy treatments.
During the Nurse track at the most recent SITC Annual Meeting, Butterfield hopes that nurses would come away with a knowledge of the options available, how the different drugs work, and how that affects the patient experience. This information should also help nurses in talking to patients and empower them when treating patients receiving immunotherapies.
Newsletter
Knowledge is power. Don’t miss the most recent breakthroughs in cancer care.
Advertisement
Advertisement
Advertisement
Trending on Oncology Nursing News
1
15,000 NYC Nurses Strike Highlights Impact on Oncology Care
2
Intensified First-Line Therapy for dMMR/MSI-H mCRC: Nursing Implications of the COMMIT Trial
3
When Are TKIs Too Aggressive for a Patient With Renal Cell Carcinoma?
4
Why Does Rina-S Target Folate Receptor Alpha in Endometrial Cancer?
5
























































































